• 2008

Company Description

Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

Esperion Therapeutics, Inc. discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called 'HDL Therapy,' which is based on the Company's understanding of high-density lipoprotein, or HDL, function.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2008
  • Company Website:

  • Company E-mail:

  • Company Address:

    3891 Ranchero Drive, Suite 150
    Ann Arbor, MI
    United States
  • CEO:

    • Tim Mayleben
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits